Emerald Organic (EMOR) to License Therapeutics Portfolio from Amarantus Bioscience Holdings (AMBS).
The portfolio includes treatments for Alzheimer’s disease, ADHD, Parkinson’s disease, vision loss and severe burns. Amarantus to receive Emerald Organics Preferred Stock for the...
Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.
Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.
Analyst Take: "Potential to be Revolutionary. Dyadic’s C1 shows potential in...
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
INVESTOR PRESENTATION
LONGER TERM CHART
Client, see published reports for disclosure and disclaimer details.
True Nature Holding (TNTY) Announces New Board Member and CEO.
Lawrence M. Diamond Joins True Nature Holding, Inc. in Board, CEO Roles, Brings Career Telehealth, Healthcare and Technology Focus
ATLANTA, GA, Oct. 07, 2019 (GLOBE...
Healthcare Incubators and Wearable Devices.
Originally published August 22, 2019
The Global Wearable Devices Market is expected to exceed more than $51.50 billion by 2022 at a CAGR of 15...
Dawson James Securities Announces 5th Annual Small Cap Growth Conference.
BOCA RATON, Fla., Sept. 25, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Dawson James Securities, Inc. (“Dawson”), a full-service boutique investment banking firm focused on emerging...
Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.
13D Filing on AYTU (As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner of 7,695,064...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click here to receive post-merger report.
INNOVUS LIVE CHART
TRADING...
AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly this morning.
This morning, the company...
Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!
Adding Fortress to Biotech Stock Review Watch List @ $1.73.
Misunderstood by Wall Street which tends to 'over-analyze' on occasion, we think the Fortress Bio...
Latest article
Fairchild Gold (FAIR.V) Advances Towards Drilling.
Fairchild Gold Advances Toward Drilling at Nevada Titan as Geophysics Sharpens Porphyry Targeting
Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - August 21, 2026)...
Hecla Mining (HL) $20.75 – Rips 33% Higher, on Incredible Numbers.
Shareholders Celebrate $4 Billion Gain in Market Value, in a Couple Weeks! And we'll drink to that!
When we added Hecla Mining (HL) to the...
A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.
Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....
